{"data":{"id":"us-in/ic-16-18-2-263.9","jurisdiction":"us-in","citation":"IC 16-18-2-263.9","heading":"\"Overdose intervention drug\"","body":"Sec. 263.9. \"Overdose intervention drug\", for purposes of IC 16-31 and IC 16-42-27, means naloxone or any other drug that:\n(1) is an opioid, opiate, or morphine antagonist; and\n(2) prevents or reverses the effects of:\n(A) opioids;\n(B) opiates; or\n(C) morphine;\nincluding respiratory depression, sedation, and hypotension.","path":["TITLE 16. HEALTH","ARTICLE 18. GENERAL PROVISIONS AND DEFINITIONS","Chapter 2. Definitions"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-18-2-263.9","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"8cd0d507b9084531ffd75d1bf314b0c8146a0629530f73655e2aa566dfa49640","source_id":"us-in","stale":false,"prev":"us-in/ic-16-18-2-263.6","next":"us-in/ic-16-18-2-264"},"notice":"GroundRules: Original legal text. Not legal advice."}